USPTO serial 98429879
VSE
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- MONINGHOFF, KIM TERESA
- Law office
- TMO LAW OFFICE 113
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Ottawa, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicole K. McLaughlin
Nicole K. McLaughlin DUANE MORRIS LLP30 South 17th StreetPhiladelphia, PA 19103-4196United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Cell culture reagents for laboratory use, namely, for research use; cell culture reagents for scientific and research purposes; antibody reagents for scientific purposes; diagnostic reagents for medical-scientific research use; chemical preparations for the use in the production of medicines; chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; biochemical preparations for scientific purposes; catalysts in the nature of small molecules for use in increasing viral yield for use in the manufacture of vaccines and viral medicines; chemical and biochemical preparations for scientific use, research use, and laboratory research use; chemical and biochemical preparations for scientific use and for scientific research use; reagents for scientific and research use, in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses, and pseudo-viral particles; chemical and biochemical preparations, agents, and reagents sold as a unit for producing viruses using transfection for scientific use and for scientific research use | ACTIVE | — |
| 040 | Biological production, namely, custom manufacture of biological preparations in the field of gene therapy and cell therapies; biological production, namely, custom manufacture of biological preparations in the field of vaccines | ACTIVE | — |
| 042 | scientific research and analysis for scientific research purposes in the field of gene and cell therapies; scientific research and analysis for scientific research purposes in the field of vaccines; research and development in the field of vaccines; testing services in the field of vaccines; laboratory research in the field of gene expression; research in the field of gene therapy; research and development in the medical biotechnology field; development of biotechnology; research and development in the pharmaceutical and biotechnology fields | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 20, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 20, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 20, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 20, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 20, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 17, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 21, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 21, 2026 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 21, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 18, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 17, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 17, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 17, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 17, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 17, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 15, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 12, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 12, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 12, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jun 12, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 11, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 11, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 11, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 9, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 9, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 1, 2024 | NWAP | NEW APPLICATION ENTERED | — |